Chiesi Farmaceutici
Europe, Emilia-Romagna, Italy, Parma
Description
Chiesi Farmaceutici provides research, development, production, and marketing of medicines for respiratory, neonatology, rare diseases.
Investor Profile
Chiesi Farmaceutici has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 33% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Private Equity, Post Ipo Debt rounds (top funding stages).
- Majority of deals are located in Canada, The Netherlands, United States.
- Strong thematic focus on Biotechnology, Health Care, Medical.
Stage Focus
- Series B (33%)
- Private Equity (33%)
- Post Ipo Debt (33%)
Country Focus
- Canada (33%)
- The Netherlands (33%)
- United States (33%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Pharmaceutical
- Genetics
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
